| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.96B | -0.5% |
| Cost of Revenue | $1.20B | -4.2% |
| R&D Expense | $174.9M | -0.7% |
| SG&A Expense | $736.0M | +11.9% |
| Operating Income | $817.7M | -6.4% |
| Interest Expense | $98.9M | +102.6% |
| Pre-tax Income | $736.2M | -12.1% |
| Income Tax | $94.0M | -27.7% |
| Net Income | $642.2M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $395.1M | -17.8% |
| Short-term Investments | $898K | +4.2% |
| Accounts Receivable | $702.2M | -2.9% |
| Inventory | $516.2M | +13.3% |
| Current Assets | $1.75B | -0.6% |
| Total Assets | $4.63B | +41.0% |
| Current Liabilities | $789.6M | +0.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $602.8M | -1.4% |
| Investing Cash Flow | -$1.44B | -1235.8% |
| Financing Cash Flow | $755.0M | +248.1% |
| -9.3% |
| EPS (Basic) | $10.87 | -7.9% |
| EPS (Diluted) | $10.84 | -7.6% |
| Long-term Debt |
| $2.36B |
| +49.4% |
| Total Liabilities | $3.48B | +25.2% |
| Stockholders' Equity | $1.15B | +128.0% |